Estimating the global cost of vision impairment and its major causes: protocol for a systematic review
Ana Patricia Marques, Jacqueline Ramke, John Cairns, Thomas Butt, Justine H Zhang, Hannah B Faal, Hugh Taylor, Iain Jones, Nathan Congdon, Andrew Bastawrous, Tasanee Braithwaite, Marty Jovic, Serge Resnikoff, Allyala Nandakumar, Peng Tee Khaw, Rupert RA Bourne, Iris Gordon, Kevin Frick, Matthew J Burton
BMJ OPEN | BMJ PUBLISHING GROUP | Published : 2020
Introduction Vision impairment (VI) places a burden on individuals, health systems and society in general. In order to support the case for investing in eye health services, an updated cost of illness study that measures the global impact of VI is necessary. To perform such a study, a systematic review of the literature is needed. Here we outline the protocol for a systematic review to describe and summarise the costs associated with VI and its major causes. Methods and analysis We will systematically search in Medline (Ovid) and the Centre for Reviews and Dissemination database which includes the National Health Service Economics Evaluation Database. No language or geographical restriction..View full abstract
Awarded by Wellcome Trust
Awarded by Moorfields Eye Charity
MJB is supported by the Wellcome Trust (207472/Z/17/Z). JR is a Commonwealth Rutherford Fellow funded by the UK government through the Commonwealth Scholarship Commission in the UK. The Lancet Global Health Commission on Global Eye Health is supported by The Queen Elizabeth Diamond Jubilee Trust, Moorfields Eye Charity [grant number GR001061], NIHR Moorfields Biomedical Research Centre, The Wellcome Trust, Sightsavers International, The Fred Hollows Foundation, The SEVA Foundation, The British Council for the Prevention of Blindness and Christian Blind Mission.